Beam Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-3.47-3.48-3.48-4.83
Price/Sales ratio
21.4718.8113.645.15
Earnings per Share (EPS)
$-4.72$-4.71$-4.69$-3.38

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-30.35-5.71-12.27-14.87-14.99-10.38-15.84-7.36-13.57
Price/Sales ratio
N/AN/A53.47K158.97K98.7244.945.5634.9579.53K
Price/Book Value ratio
-58.064.919.5315.536.193.732.142.9010.86
Price/Cash Flow ratio
-89.71-32.45-13.36-39.85-77.23121.55-14.0794.53-26.60
Price/Free Cash Flow ratio
-79.55-19.71-11.38-34.03-45.26-103.62-11.48-80.59-39.64
Price/Earnings Growth ratio
N/A-0.010.23-0.054.570.350.29-0.252.25
Dividend Yield
N/AN/A1.32%N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A-29938.88%-429812.5%68.28%62.93%-15.79%N/A-229875.69%
Operating Profit Margin
N/AN/A-417522.22%-553166.66%-757.01%-555.61%-46.72%-555.61%-485344.44%
Pretax Profit Margin
N/AN/A-435144.44%-810800%-714.91%-427.08%-34.72%-427.08%-622972.22%
Net Profit Margin
N/AN/A-435788.88%-1068433.33%-658.43%-432.67%-35.08%-474.53%-752111.11%
Effective Tax Rate
-6.24%60.81%-0.14%-31.77%7.89%-1.31%-1.04%-1.31%-16.54%
Return on Assets
-333.13%-69.01%-50.25%-56.77%-23.15%-19.64%-9.07%-21.54%-53.51%
Return On Equity
191.29%-85.99%-77.70%-104.42%-41.29%-35.93%-13.50%-37.57%-91.06%
Return on Capital Employed
189.28%-32.34%-59.19%-38.00%-31.12%-30.27%-14.07%-30.27%-48.59%
Liquidity Ratios
Current Ratio
N/AN/AN/A3.01N/AN/AN/A4.883.95
Quick Ratio
0.315.793.243.017.364.885.894.823.12
Cash ratio
0.285.721.271.584.521.042.121.043.05
Days of Sales Outstanding
N/AN/AN/AN/A2.11KN/AN/AN/A1.05K
Days of Inventory outstanding
N/AN/AN/AN/A-13.48KN/AN/AN/A-6.74K
Operating Cycle
N/AN/AN/AN/A-11.37KN/AN/AN/A-5.68K
Days of Payables Outstanding
24.09K4.12K529.6422.33165.92145.971.34N/A94.13
Cash Conversion Cycle
N/AN/A-529.64-22.33-11.53K-145.97-1.34N/A-275.99
Debt Ratios
Debt Ratio
0.42N/AN/AN/A0.000.00N/A0.450.22
Debt Equity Ratio
-0.24N/AN/AN/A0.000.00N/A0.820.41
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.18N/A
Total Debt to Capitalization
-0.31N/AN/AN/A0.000.00N/A0.190.09
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-22.12N/A
Cash Flow to Debt Ratio
-2.68N/AN/AN/A-28.9712.15N/A0.12-14.48
Company Equity Multiplier
-0.571.241.541.831.781.821.481.821.81
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-4.00K-3.98K-1.270.36-0.390.36-3.99K
Free Cash Flow / Operating Cash Flow Ratio
1.121.641.171.171.70-1.171.22-1.171.43
Cash Flow Coverage Ratio
-2.68N/AN/AN/A-28.9712.15N/A0.12-14.48
Short Term Coverage Ratio
-2.68N/AN/AN/A-28.9712.15N/A2.17-14.48
Dividend Payout Ratio
N/AN/A-16.20%N/AN/AN/AN/AN/AN/A